EyePoint EYPT
NASDAQ EYPT
$3.25 +0.02 (+0.62%)
At close: Oct 2, 2026 · 4:00 PM EDT

EyePoint (EYPT) Return on Equity [ROE] (2011 - 2026)

Updated

EyePoint's Return on Equity [ROE] was -155.71% in Q2 2026, down 89.94 percentage points from -65.77% a year earlier and down 53.60 percentage points from the prior quarter.

Analysis

EyePoint (EYPT) Return on Equity [ROE] (2011 - 2026) Analysis & Trends

For FY2025, Return on Equity [ROE] at EyePoint came in at -72.19%, down 28.77 percentage points from FY2024.

  • Return on Equity [ROE] shows a five-year change of +259.37 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Equity [ROE] was -43.42% in FY2024 (-4.38 pp), -39.04% in FY2023 (+33.81 pp), -72.84% in FY2022 (-12.94 pp) and -59.90% in FY2021 (+271.66 pp).
  • The Q2 2026 figure marks the lowest quarterly Return on Equity [ROE] since Q3 2023.
  • Compared with a year earlier, Return on Equity [ROE] has declined for seven straight quarters, with an average year-over-year change of -18.00 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Equity [ROE] over five years was Q3 2021 (a gain of 635.46 percentage points); the worst was Q3 2023 (a drop of 126.27 percentage points).
  • Per Business Quant data, EYPT's Return on Equity [ROE] in the three quarters before Q2 2026 was -102.11% (Q1 2026), -93.07% (Q4 2025) and -93.86% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.32%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.21%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 84.40%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 21.39%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 83.75%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -18.38%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.97%
10 EyePoint 276.19 Mn -636.93 Mn 507,000.00 -155.71%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -155.71%
Mar 31, 2026 -102.11%
Dec 31, 2025 -93.07%
Sep 30, 2025 -93.86%
Jun 30, 2025 -65.77%
Mar 31, 2025 -47.39%
Dec 31, 2024 -48.59%
Sep 30, 2024 -49.15%
Jun 30, 2024 -39.69%
Mar 31, 2024 -33.81%
Dec 31, 2023 -46.97%
Sep 30, 2023 -180.31%
Jun 30, 2023 -160.91%
Mar 31, 2023 -120.98%
Dec 31, 2022 -88.37%
Sep 30, 2022 -54.04%
Jun 30, 2022 -47.38%
Mar 31, 2022 -38.71%
Dec 31, 2021 -43.86%
Sep 30, 2021 -56.01%
API Access

EyePoint Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=EYPT&period=max&api_key=YOUR_API_KEY